Modulation of nasopharyngeal innate defenses by viral coinfection predisposes individuals to experimental pneumococcal carriage.

PubWeight™: 0.85‹?›

🔗 View Article (PMID 25921341)

Published in Mucosal Immunol on April 29, 2015

Authors

S Glennie1, J F Gritzfeld1, S H Pennington1, M Garner-Jones1, N Coombes1, M J Hopkins2, C F Vadesilho3, E N Miyaji3, D Wang4, A D Wright1,5, A M Collins1,5, S B Gordon1, D M Ferreira1

Author Affiliations

1: Respiratory Infection Group, Liverpool School of Tropical Medicine, Liverpool, UK.
2: Liverpool Specialist Virology Centre, Royal Liverpool and Broadgreen University Hospital, Liverpool, UK.
3: Centro de Biotecnologia, Instituto Butantan, Sao Paulo, Brazil.
4: Tropical Clinical Trial Unit, Liverpool School of Tropical Medicine, Liverpool, UK.
5: NIHR Royal Liverpool and Broadgreen University Hospital NHS Trust, Liverpool, UK.

Articles cited by this

Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J Infect Dis (2008) 11.01

Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet Infect Dis (2004) 9.73

Epidemiologic studies of Streptococcus pneumoniae in infants: acquisition, carriage, and infection during the first 24 months of life. J Infect Dis (1980) 7.45

Host polymorphisms in interleukin 4, complement factor H, and C-reactive protein associated with nasal carriage of Staphylococcus aureus and occurrence of boils. J Infect Dis (2008) 7.45

The role of Streptococcus pneumoniae virulence factors in host respiratory colonization and disease. Nat Rev Microbiol (2008) 5.98

The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum resistance. J Immunol (2006) 3.62

Immunogenicity and tolerability of a multicomponent meningococcal serogroup B (4CMenB) vaccine in healthy adolescents in Chile: a phase 2b/3 randomised, observer-blind, placebo-controlled study. Lancet (2012) 3.21

The pspC gene of Streptococcus pneumoniae encodes a polymorphic protein, PspC, which elicits cross-reactive antibodies to PspA and provides immunity to pneumococcal bacteremia. Infect Immun (1999) 2.94

Sustained desensitization to bacterial Toll-like receptor ligands after resolution of respiratory influenza infection. J Exp Med (2008) 2.77

Influenza enhances susceptibility to natural acquisition of and disease due to Streptococcus pneumoniae in ferrets. J Infect Dis (2010) 2.77

Role of pneumococcal surface protein C in nasopharyngeal carriage and pneumonia and its ability to elicit protection against carriage of Streptococcus pneumoniae. Infect Immun (2002) 2.15

The airway epithelium: soldier in the fight against respiratory viruses. Clin Microbiol Rev (2011) 2.05

Influenza virus infection decreases tracheal mucociliary velocity and clearance of Streptococcus pneumoniae. Am J Respir Cell Mol Biol (2009) 1.95

Association between nasopharyngeal load of Streptococcus pneumoniae, viral coinfection, and radiologically confirmed pneumonia in Vietnamese children. Pediatr Infect Dis J (2011) 1.92

PspC, a pneumococcal surface protein, binds human factor H. Infect Immun (2001) 1.92

Streptococcus pneumoniae evades complement attack and opsonophagocytosis by expressing the pspC locus-encoded Hic protein that binds to short consensus repeats 8-11 of factor H. J Immunol (2002) 1.87

Controlled human infection and rechallenge with Streptococcus pneumoniae reveals the protective efficacy of carriage in healthy adults. Am J Respir Crit Care Med (2013) 1.84

Synergistic stimulation of type I interferons during influenza virus coinfection promotes Streptococcus pneumoniae colonization in mice. J Clin Invest (2011) 1.79

Immunogenicity of two investigational serogroup B meningococcal vaccines in the first year of life: a randomized comparative trial. Pediatr Infect Dis J (2010) 1.73

A meningococcal factor H binding protein mutant that eliminates factor H binding enhances protective antibody responses to vaccination. J Immunol (2011) 1.68

The host immune regulator factor H interacts via two contact sites with the PspC protein of Streptococcus pneumoniae and mediates adhesion to host epithelial cells. J Immunol (2007) 1.58

Species-specific binding of human secretory component to SpsA protein of Streptococcus pneumoniae via a hexapeptide motif. Mol Microbiol (2000) 1.56

Viral and atypical bacterial detection in acute respiratory infection in children under five years. PLoS One (2011) 1.56

Dual roles of PspC, a surface protein of Streptococcus pneumoniae, in binding human secretory IgA and factor H. J Immunol (2004) 1.41

Characterization of protective mucosal and systemic immune responses elicited by pneumococcal surface protein PspA and PspC nasal vaccines against a respiratory pneumococcal challenge in mice. Clin Vaccine Immunol (2009) 1.18

Human nasal challenge with Streptococcus pneumoniae is immunising in the absence of carriage. PLoS Pathog (2012) 1.18

High nasopharyngeal pneumococcal density, increased by viral coinfection, is associated with invasive pneumococcal pneumonia. J Infect Dis (2014) 1.14

Complement regulator Factor H mediates a two-step uptake of Streptococcus pneumoniae by human cells. J Biol Chem (2010) 1.13

The effects of PspC on complement-mediated immunity to Streptococcus pneumoniae vary with strain background and capsular serotype. Infect Immun (2009) 1.11

Experimental human pneumococcal carriage. J Vis Exp (2013) 1.09

Species-specific interaction of Streptococcus pneumoniae with human complement factor H. J Immunol (2008) 1.08

Influenza virus induces bacterial and nonbacterial otitis media. J Infect Dis (2011) 1.08

Structured regulation of inflammation during respiratory viral infection. Lancet Infect Dis (2010) 1.02

The choline-binding protein PspC of Streptococcus pneumoniae interacts with the C-terminal heparin-binding domain of vitronectin. J Biol Chem (2013) 1.01

Experimental human pneumococcal carriage models for vaccine research. Trends Microbiol (2011) 1.01

Experimental human pneumococcal carriage augments IL-17A-dependent T-cell defence of the lung. PLoS Pathog (2013) 1.01

Factor H binding to PspC of Streptococcus pneumoniae increases adherence to human cell lines in vitro and enhances invasion of mouse lungs in vivo. Infect Immun (2007) 0.94

Pneumococcal IgA1 protease subverts specific protection by human IgA1. Mucosal Immunol (2013) 0.94

Effect of the 2009 influenza A(H1N1) pandemic on invasive pneumococcal pneumonia. J Infect Dis (2013) 0.90

Group B meningococcal vaccine: recommendations for UK use. Lancet (2014) 0.89

Using the full spectral capacity (six channels) of a real-time PCR instrument can simplify diagnostic laboratory screening and typing protocols for pandemic H1N1 influenza. Influenza Other Respir Viruses (2010) 0.87

Innate immunity modulation in virus entry. Curr Opin Virol (2011) 0.86

Nasal immunization of mice with Lactobacillus casei expressing the pneumococcal surface protein C primes the immune system and decreases pneumococcal nasopharyngeal colonization in mice. FEMS Immunol Med Microbiol (2011) 0.86

Interaction of clinical isolates of Streptococcus pneumoniae with human complement factor H. FEMS Microbiol Lett (2006) 0.83

Development of cross-reactive antibodies to the proline-rich region of pneumococcal surface protein A in children. Vaccine (2012) 0.83

Transcriptional adaptation of pneumococci and human pharyngeal cells in the presence of a virus infection. BMC Genomics (2013) 0.78

C3b/iC3b deposition on Streptococcus pneumoniae is not affected by HIV infection. PLoS One (2010) 0.76

Mapping of epitopes recognized by antibodies induced by immunization of mice with PspA and PspC. Clin Vaccine Immunol (2014) 0.76